MersV1, PubMed, Corpus, bibRecord, 000768

The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts.

Identifieur interne : 000768 ( PubMed/Corpus ); précédent : 000767; suivant : 000769

The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts.

Auteurs : Massinissa Si Mehand ; Farah Al-Shorbaji ; Piers Millett ; Bernadette Murgue

Source :

Antiviral research [ 1872-9096 ] ; 2018.

RBID : pubmed:30261226

English descriptors

KwdEn :
- Animals, Communicable Diseases, Emerging, Humans, Research (statistics & numerical data), Research Report, Virus Diseases (diagnosis), Virus Diseases (prevention & control), Virus Diseases (therapy), World Health Organization.
MESH :
- diagnosis : Virus Diseases.
- prevention & control : Virus Diseases.
- statistics & numerical data : Research.
- therapy : Virus Diseases.
- Animals, Communicable Diseases, Emerging, Humans, Research Report, World Health Organization.

Abstract

The Research and Development (R&D) Blueprint is a World Health Organization initiative to reduce the time between the declaration of a public health emergency and the availability of effective diagnostic tests, vaccines, and treatments that can save lives and avert a public health crisis. The scope of the Blueprint extends to severe emerging diseases for which there are insufficient or no presently existing medical countermeasures or pipelines to produce them. In February 2018, WHO held an informal expert consultation to review and update the list of priority diseases, employing a prioritization methodology which uses the Delphi technique, questionnaires, multi-criteria decision analysis, and expert review to identify relevant diseases. The committee determined that, given their potential to cause a public health emergency and the absence of efficacious drugs and/or vaccines, there is an urgent need for accelerated R&D for (in no order of priority) Crimean-Congo haemorrhagic fever, Ebola virus and Marburg virus disease, Lassa fever, Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS), Nipah and henipaviral diseases, Rift Valley fever and Zika virus disease. The experts also included "Disease X," representing the awareness that a previously unknown pathogen could cause a major public health emergency. This report describes the methods and results of the 2018 prioritization review.

DOI: 10.1016/j.antiviral.2018.09.009
PubMed: 30261226

Links to Exploration step

pubmed:30261226

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts.</title>
<author><name sortKey="Mehand, Massinissa Si" sort="Mehand, Massinissa Si" uniqKey="Mehand M" first="Massinissa Si" last="Mehand">Massinissa Si Mehand</name>
<affiliation><nlm:affiliation>World Health Organization, Switzerland. Electronic address: simehandm@who.int.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Al Shorbaji, Farah" sort="Al Shorbaji, Farah" uniqKey="Al Shorbaji F" first="Farah" last="Al-Shorbaji">Farah Al-Shorbaji</name>
<affiliation><nlm:affiliation>World Health Organization, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Millett, Piers" sort="Millett, Piers" uniqKey="Millett P" first="Piers" last="Millett">Piers Millett</name>
<affiliation><nlm:affiliation>Future of Humanity Institute, University of Oxford, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Murgue, Bernadette" sort="Murgue, Bernadette" uniqKey="Murgue B" first="Bernadette" last="Murgue">Bernadette Murgue</name>
<affiliation><nlm:affiliation>World Health Organization, Switzerland.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:30261226</idno>
<idno type="pmid">30261226</idno>
<idno type="doi">10.1016/j.antiviral.2018.09.009</idno>
<idno type="wicri:Area/PubMed/Corpus">000768</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000768</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts.</title>
<author><name sortKey="Mehand, Massinissa Si" sort="Mehand, Massinissa Si" uniqKey="Mehand M" first="Massinissa Si" last="Mehand">Massinissa Si Mehand</name>
<affiliation><nlm:affiliation>World Health Organization, Switzerland. Electronic address: simehandm@who.int.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Al Shorbaji, Farah" sort="Al Shorbaji, Farah" uniqKey="Al Shorbaji F" first="Farah" last="Al-Shorbaji">Farah Al-Shorbaji</name>
<affiliation><nlm:affiliation>World Health Organization, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Millett, Piers" sort="Millett, Piers" uniqKey="Millett P" first="Piers" last="Millett">Piers Millett</name>
<affiliation><nlm:affiliation>Future of Humanity Institute, University of Oxford, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Murgue, Bernadette" sort="Murgue, Bernadette" uniqKey="Murgue B" first="Bernadette" last="Murgue">Bernadette Murgue</name>
<affiliation><nlm:affiliation>World Health Organization, Switzerland.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Antiviral research</title>
<idno type="eISSN">1872-9096</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Communicable Diseases, Emerging</term>
<term>Humans</term>
<term>Research (statistics & numerical data)</term>
<term>Research Report</term>
<term>Virus Diseases (diagnosis)</term>
<term>Virus Diseases (prevention & control)</term>
<term>Virus Diseases (therapy)</term>
<term>World Health Organization</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Virus Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Virus Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Research</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Virus Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Communicable Diseases, Emerging</term>
<term>Humans</term>
<term>Research Report</term>
<term>World Health Organization</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The Research and Development (R&D) Blueprint is a World Health Organization initiative to reduce the time between the declaration of a public health emergency and the availability of effective diagnostic tests, vaccines, and treatments that can save lives and avert a public health crisis. The scope of the Blueprint extends to severe emerging diseases for which there are insufficient or no presently existing medical countermeasures or pipelines to produce them. In February 2018, WHO held an informal expert consultation to review and update the list of priority diseases, employing a prioritization methodology which uses the Delphi technique, questionnaires, multi-criteria decision analysis, and expert review to identify relevant diseases. The committee determined that, given their potential to cause a public health emergency and the absence of efficacious drugs and/or vaccines, there is an urgent need for accelerated R&D for (in no order of priority) Crimean-Congo haemorrhagic fever, Ebola virus and Marburg virus disease, Lassa fever, Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS), Nipah and henipaviral diseases, Rift Valley fever and Zika virus disease. The experts also included "Disease X," representing the awareness that a previously unknown pathogen could cause a major public health emergency. This report describes the methods and results of the 2018 prioritization review.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30261226</PMID>
<DateCompleted><Year>2019</Year>
<Month>09</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-9096</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>159</Volume>
<PubDate><Year>2018</Year>
<Month>11</Month>
</PubDate>
</JournalIssue>
<Title>Antiviral research</Title>
<ISOAbbreviation>Antiviral Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts.</ArticleTitle>
<Pagination><MedlinePgn>63-67</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0166-3542(18)30564-3</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.antiviral.2018.09.009</ELocationID>
<Abstract><AbstractText>The Research and Development (R&D) Blueprint is a World Health Organization initiative to reduce the time between the declaration of a public health emergency and the availability of effective diagnostic tests, vaccines, and treatments that can save lives and avert a public health crisis. The scope of the Blueprint extends to severe emerging diseases for which there are insufficient or no presently existing medical countermeasures or pipelines to produce them. In February 2018, WHO held an informal expert consultation to review and update the list of priority diseases, employing a prioritization methodology which uses the Delphi technique, questionnaires, multi-criteria decision analysis, and expert review to identify relevant diseases. The committee determined that, given their potential to cause a public health emergency and the absence of efficacious drugs and/or vaccines, there is an urgent need for accelerated R&D for (in no order of priority) Crimean-Congo haemorrhagic fever, Ebola virus and Marburg virus disease, Lassa fever, Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS), Nipah and henipaviral diseases, Rift Valley fever and Zika virus disease. The experts also included "Disease X," representing the awareness that a previously unknown pathogen could cause a major public health emergency. This report describes the methods and results of the 2018 prioritization review.</AbstractText>
<CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mehand</LastName>
<ForeName>Massinissa Si</ForeName>
<Initials>MS</Initials>
<AffiliationInfo><Affiliation>World Health Organization, Switzerland. Electronic address: simehandm@who.int.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Al-Shorbaji</LastName>
<ForeName>Farah</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>World Health Organization, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Millett</LastName>
<ForeName>Piers</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Future of Humanity Institute, University of Oxford, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Murgue</LastName>
<ForeName>Bernadette</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>World Health Organization, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID>
<Agency>World Health Organization</Agency>
<Country>International</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2018</Year>
<Month>09</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Antiviral Res</MedlineTA>
<NlmUniqueID>8109699</NlmUniqueID>
<ISSNLinking>0166-3542</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D021821" MajorTopicYN="Y">Communicable Diseases, Emerging</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012106" MajorTopicYN="N">Research</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058028" MajorTopicYN="N">Research Report</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014944" MajorTopicYN="Y">World Health Organization</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Experts' opinions</Keyword>
<Keyword MajorTopicYN="Y">Multi-criteria decision analysis</Keyword>
<Keyword MajorTopicYN="Y">Multidisciplinary method</Keyword>
<Keyword MajorTopicYN="Y">Prioritization</Keyword>
<Keyword MajorTopicYN="Y">Severe emerging infectious diseases</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year>
<Month>09</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2018</Year>
<Month>09</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2018</Year>
<Month>9</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>9</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2018</Year>
<Month>9</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">30261226</ArticleId>
<ArticleId IdType="pii">S0166-3542(18)30564-3</ArticleId>
<ArticleId IdType="doi">10.1016/j.antiviral.2018.09.009</ArticleId>
<ArticleId IdType="pmc">PMC7113760</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Value Health. 2016 Jan;19(1):1-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26797229</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Value Health. 2016 Mar-Apr;19(2):125-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27021745</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2018 Sep;24(9):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30124424</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000768 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000768 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:30261226
   |texte=   The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:30261226" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021

	Serveur d'exploration MERS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration MERS

The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts.

The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki